Experience and perpetration of intimate partner violence and abuse by gender of respondent and their current partner before and during COVID-19 restrictions in 2020: a cross-sectional study in 13 countries.
COVID-19
Gender and sexual minorities
Intimate partner violence and abuse
LGBTQI+
Non-binary
Transgender
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
13 02 2023
13 02 2023
Historique:
received:
17
01
2022
accepted:
15
11
2022
entrez:
14
2
2023
pubmed:
15
2
2023
medline:
16
2
2023
Statut:
epublish
Résumé
Intimate partner violence and abuse (IPVA) includes controlling behaviours, psychological, physical, sexual and financial abuse. Globally, surveys and emergency services have recorded an increase in IPVA since restrictions were imposed to limit COVID-19 transmission. Most studies have only included heterosexual women. Data from the Global Drug Survey (an annual, anonymous, online survey collecting data on drug use) Special Edition were analysed to explore the impact of COVID-19 on people's lives, including their intimate relationships. Five relationship groupings were created using respondents' lived gender identity: women partnered with men (46.9%), women partnered with women (2.1%), men partnered with men (2.9%), men partnered with women (47.2%), and partnerships where one or both partners were non-binary (1%). Self-reported experience and perpetration of IPVA in the past 30 days before (February) and during COVID-19 restrictions (May or June) in 2020 (N = 35,854) was described and compared for different relationship groupings using Fishers Exact Tests. Changes in IPVA during restrictions were assessed using multivariable logistic regression. During restrictions, 17.8 and 16.6% of respondents had experienced or perpetrated IPVA respectively; 38.2% of survivors and 37.6% of perpetrators reported this had increased during restrictions. Greater proportions of non-binary respondents or respondents with a non-binary partner reported experiencing or perpetrating IPVA (p < .001) than other relationship groupings. 22.0% of respondents who were non-binary or had a non-binary partner, 19.5% of men partnered with men, 18.9% of men partnered with women, 17.1% of women partnered with women and 16.6% of women partnered with men reported experiencing IPVA. Respondents with higher psychological distress, poor coping with pandemic-related changes, relationship tension and changes (increases or increases and decreases) in alcohol consumption reported increased experience of IPVA during restrictions. This study confirmed that IPVA can occur in all intimate relationships, regardless of gender of the perpetrator or survivor. Non-binary respondents or respondents with non-binary partners reported the highest use and experience of IPVA. Most IPVA victim support services have been designed for heterosexual, cisgender women. IPVA support services and perpetrator programmes must be tailored to support all perpetrators and survivors during the pandemic and beyond, regardless of their sexual or gender identity.
Sections du résumé
BACKGROUND
Intimate partner violence and abuse (IPVA) includes controlling behaviours, psychological, physical, sexual and financial abuse. Globally, surveys and emergency services have recorded an increase in IPVA since restrictions were imposed to limit COVID-19 transmission. Most studies have only included heterosexual women.
METHODS
Data from the Global Drug Survey (an annual, anonymous, online survey collecting data on drug use) Special Edition were analysed to explore the impact of COVID-19 on people's lives, including their intimate relationships. Five relationship groupings were created using respondents' lived gender identity: women partnered with men (46.9%), women partnered with women (2.1%), men partnered with men (2.9%), men partnered with women (47.2%), and partnerships where one or both partners were non-binary (1%). Self-reported experience and perpetration of IPVA in the past 30 days before (February) and during COVID-19 restrictions (May or June) in 2020 (N = 35,854) was described and compared for different relationship groupings using Fishers Exact Tests. Changes in IPVA during restrictions were assessed using multivariable logistic regression.
RESULTS
During restrictions, 17.8 and 16.6% of respondents had experienced or perpetrated IPVA respectively; 38.2% of survivors and 37.6% of perpetrators reported this had increased during restrictions. Greater proportions of non-binary respondents or respondents with a non-binary partner reported experiencing or perpetrating IPVA (p < .001) than other relationship groupings. 22.0% of respondents who were non-binary or had a non-binary partner, 19.5% of men partnered with men, 18.9% of men partnered with women, 17.1% of women partnered with women and 16.6% of women partnered with men reported experiencing IPVA. Respondents with higher psychological distress, poor coping with pandemic-related changes, relationship tension and changes (increases or increases and decreases) in alcohol consumption reported increased experience of IPVA during restrictions.
CONCLUSIONS
This study confirmed that IPVA can occur in all intimate relationships, regardless of gender of the perpetrator or survivor. Non-binary respondents or respondents with non-binary partners reported the highest use and experience of IPVA. Most IPVA victim support services have been designed for heterosexual, cisgender women. IPVA support services and perpetrator programmes must be tailored to support all perpetrators and survivors during the pandemic and beyond, regardless of their sexual or gender identity.
Identifiants
pubmed: 36782157
doi: 10.1186/s12889-022-14635-2
pii: 10.1186/s12889-022-14635-2
pmc: PMC9924203
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
316Informations de copyright
© 2023. The Author(s).
Références
Subst Abuse. 2017 Jun 30;11:1178221817716391
pubmed: 28924351
Bull World Health Organ. 2021 Jun 01;99(6):429-438
pubmed: 34108753
J Interpers Violence. 2021 Jan;36(1-2):381-405
pubmed: 29294898
Alcohol Clin Exp Res. 2020 Oct;44(10):2073-2083
pubmed: 32870516
LGBT Health. 2016 Dec;3(6):400-406
pubmed: 27906642
AIDS Behav. 2021 Jan;25(1):40-48
pubmed: 32876905
Am J Public Health. 2023 Feb;113(2):228-237
pubmed: 36302221
Partner Abuse. 2012 Apr;3(2):231-280
pubmed: 22754606
Inj Prev. 2021 Feb;27(1):93-97
pubmed: 32873603
PLoS Med. 2014 Mar 04;11(3):e1001609
pubmed: 24594975
PLoS Med. 2019 Dec 17;16(12):e1002995
pubmed: 31846461
J Sex Med. 2020 Oct;17(10):1827-1834
pubmed: 32883631
J Affect Disord. 2021 Feb 15;281:91-98
pubmed: 33310451
BMJ. 1995 Jan 21;310(6973):170
pubmed: 7833759
J Couns Psychol. 2019 Jul;66(4):385-395
pubmed: 30896208
Soc Sci Med. 2020 Jan 15;247:112804
pubmed: 31978704
Sex Med. 2021 Dec;9(6):100433
pubmed: 34571326
Drug Alcohol Rev. 2021 Sep;40(6):890-899
pubmed: 33657644
J Sex Res. 2018 May -Jun;55(4-5):435-456
pubmed: 29099625
Psychiatry Clin Neurosci. 2020 Oct;74(10):542-549
pubmed: 32602150
BMC Public Health. 2019 Apr 25;19(1):431
pubmed: 31023281
J Psychiatr Res. 2019 Dec;119:1-6
pubmed: 31518909
LGBT Health. 2022 Nov;9(8):534-542
pubmed: 35878065
Trauma Violence Abuse. 2016 Jul;17(3):284-97
pubmed: 26018210
Front Psychol. 2019 Jun 25;10:1453
pubmed: 31293486
J Homosex. 2020 Aug 23;67(10):1471-1489
pubmed: 30912709
LGBT Health. 2016 Jun;3(3):193-9
pubmed: 27046450
Psychiatry Clin Neurosci. 2021 Feb;75(2):64-66
pubmed: 33225558
Heliyon. 2021 Mar 30;7(3):e06619
pubmed: 33869852
Psychol Bull. 2000 Sep;126(5):651-680
pubmed: 10989615
J Fam Pract. 2000 Oct;49(10):896-903
pubmed: 11052161
Trauma Violence Abuse. 2016 Dec;17(5):585-600
pubmed: 25979872
Arch Gen Psychiatry. 2003 Feb;60(2):184-9
pubmed: 12578436
Sci Rep. 2021 Apr 14;11(1):8139
pubmed: 33854103
Sex Transm Infect. 2021 Jun;97(4):268-275
pubmed: 33833086
Drug Alcohol Depend. 2021 Dec 1;229(Pt A):109150
pubmed: 34749198
Violence Vict. 2014;29(5):784-96
pubmed: 25905128
Appl Psychol Health Well Being. 2023 Feb;15(1):80-96
pubmed: 35666060
J Interpers Violence. 2021 Nov;36(21-22):NP11968-NP11993
pubmed: 31789088
BMJ. 2020 May 11;369:m1872
pubmed: 32393463
Int J Methods Psychiatr Res. 2012 Jun;21(2):88-97
pubmed: 22351472
Cad Saude Publica. 2020 Nov 20;36(12):e00202420
pubmed: 33237252
Psychiatry Res. 2020 Oct;292:113365
pubmed: 32862107
LGBT Health. 2021 May-Jun;8(4):263-272
pubmed: 33887160
BMC Int Health Hum Rights. 2016 Jan 14;16:2
pubmed: 26769484
Int J Epidemiol. 2013 Aug;42(4):1012-4
pubmed: 24062287
Addict Behav. 2022 Dec;135:107439
pubmed: 35914417
Lancet. 2021 Nov 6;398(10312):1700-1712
pubmed: 34634250
Aust J Soc Issues. 2021 Sep;56(3):359-373
pubmed: 34188336
Trauma Violence Abuse. 2013 Apr;14(2):168-85
pubmed: 23271429
Am J Drug Alcohol Abuse. 2021 Jan 2;47(1):98-106
pubmed: 33280423
J Public Health (Oxf). 2022 Mar 21;:
pubmed: 35312006
J Homosex. 2021 Mar 21;68(4):592-611
pubmed: 33502286
Int J Law Psychiatry. 2020 Jul - Aug;71:101606
pubmed: 32768122
Br J Psychiatry. 2021 Jun;218(6):326-333
pubmed: 33081860
Am J Public Health. 2020 Sep;110(9):e1-e14
pubmed: 32673114
EClinicalMedicine. 2020 Apr 11;21:100348
pubmed: 32292900
JMIR Public Health Surveill. 2020 Jul 30;6(3):e19831
pubmed: 32678797
JMIR Ment Health. 2020 Mar 26;7(3):e18848
pubmed: 32213476
Am J Epidemiol. 2021 Dec 1;190(12):2712-2717
pubmed: 34409983
J Interpers Violence. 2022 Aug;37(15-16):NP14166-NP14188
pubmed: 33866839
BMJ Open. 2019 Jun 11;9(6):e021960
pubmed: 31186243
Psychol Violence. 2022 Mar;12(2):95-103
pubmed: 35310779
BMJ Open. 2016 Dec 7;6(12):e012824
pubmed: 27927659
PLoS One. 2021 Jul 9;16(7):e0254215
pubmed: 34242317
Int J Ment Health Nurs. 2020 Jun;29(3):315-318
pubmed: 32277578
JAMA Netw Open. 2022 Apr 1;5(4):e227629
pubmed: 35452109
Drug Alcohol Rev. 2017 Jan;36(1):7-9
pubmed: 27305859
Trauma Violence Abuse. 2021 Apr;22(2):233-248
pubmed: 33205700
Am J Crim Justice. 2020;45(4):601-635
pubmed: 32837161
Lancet. 2016 Jul 23;388(10042):390-400
pubmed: 27323925
Front Psychiatry. 2020 Nov 04;11:542301
pubmed: 33329083
Arch Womens Ment Health. 2020 Dec;23(6):749-756
pubmed: 33068161
Lancet. 2022 Feb 26;399(10327):803-813
pubmed: 35182472
Trauma Violence Abuse. 2019 Jul;20(3):374-384
pubmed: 29333967
Violence Vict. 2010;25(5):588-603
pubmed: 21061866
N Engl J Med. 2020 Dec 10;383(24):2302-2304
pubmed: 32937063
Psychol Med. 2002 Aug;32(6):959-76
pubmed: 12214795